Peter Nelson and colleagues at UW complete first comprehensive assessment of DNA errors that may drive lethal, treatment-resistant disease
Oct. 3, 2011
| By Kristen Woodward
A team of researchers at the Fred Hutchinson Cancer Research Center and University of Washington has conducted the first comprehensive assessment of every gene in the genome of advanced, lethal prostate cancer. Until now, the genetic composition of such tumors had been poorly defined. In the process, they have discovered a number of potential key drivers—recurrent genetic mistakes—common to advanced prostate cancer that may contribute to disease progression.
Fred Hutch is proud to be an Equal Opportunity and VEVRAA Employer. We are committed to cultivating a workplace in which diverse perspectives and experiences are welcomed and respected. We do not discriminate on the basis of race, color, religion, creed, ancestry, national origin, sex, age, disability, marital or veteran status, sexual orientation, gender identity, political ideology, or membership in any other legally protected class. We are an Affirmative Action employer. We encourage individuals with diverse backgrounds to apply and desire priority referrals of protected veterans. Read the EEO is the Law poster here.